Cargando…

A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

BACKGROUND: This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). METHODS: Patients diagnosed with EOC during 2012–2015 were an...

Descripción completa

Detalles Bibliográficos
Autores principales: Eoh, Kyung Jin, Yoon, Jung Won, Lee, Jung-Yun, Nam, Eun Ji, Kim, Sunghoon, Kim, Sang Wun, Kim, Young Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508631/
https://www.ncbi.nlm.nih.gov/pubmed/28701190
http://dx.doi.org/10.1186/s12885-017-3476-1
_version_ 1783249907098845184
author Eoh, Kyung Jin
Yoon, Jung Won
Lee, Jung-Yun
Nam, Eun Ji
Kim, Sunghoon
Kim, Sang Wun
Kim, Young Tae
author_facet Eoh, Kyung Jin
Yoon, Jung Won
Lee, Jung-Yun
Nam, Eun Ji
Kim, Sunghoon
Kim, Sang Wun
Kim, Young Tae
author_sort Eoh, Kyung Jin
collection PubMed
description BACKGROUND: This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). METHODS: Patients diagnosed with EOC during 2012–2015 were analyzed retrospectively. Surgical and survival outcomes were compared between three treatment groups: patients without high tumor dissemination (HTD) who underwent primary debulking surgery (PDS group); patients with HTD who underwent DLS (DLS group); and patients with HTD diagnosed by cytological confirmation of malignancy followed by neoadjuvant chemotherapy (NACT group). RESULTS: Of 181 patients, 85, 38, and 58 underwent PDS, DLS, and NACT, respectively. Among the 38 consecutive patients who initially underwent DLS, 6 were considered suitable for PDS; the remaining 32 were eligible for NACT followed by interval debulking surgery. The median operative times of debulking surgery in the PDS, DLS, and NACT groups were 365 min (interquartile range [IQR]: 216.5–476.5 min), 266.2 min (IQR: 160.3–193.5 min), and 339.0 min (IQR: 205–425 min; P = 0.042), respectively, with respective median estimated blood loss volumes of 962.2 mL (IQR: 300–1037.5 mL), 267.1 mL (IQR: 150–450 mL), and 861.7 mL (IQR: 150–1200 mL; P = 0.023). The DLS group had significantly reduced transfusion requirements and intensive care unit admission rates (P = 0.006). The Kaplan–Meier survival analysis indicated significantly poor PFS in the NACT group. However, there was no significant difference in OS among the three groups. CONCLUSIONS: The consecutive steps of imaging, frailty assessment, and DLS might facilitate rapid assessments of peritoneal disease extent and resectability; this novel algorithm might also be used to individualize treatment.
format Online
Article
Text
id pubmed-5508631
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55086312017-07-17 A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy Eoh, Kyung Jin Yoon, Jung Won Lee, Jung-Yun Nam, Eun Ji Kim, Sunghoon Kim, Sang Wun Kim, Young Tae BMC Cancer Research Article BACKGROUND: This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). METHODS: Patients diagnosed with EOC during 2012–2015 were analyzed retrospectively. Surgical and survival outcomes were compared between three treatment groups: patients without high tumor dissemination (HTD) who underwent primary debulking surgery (PDS group); patients with HTD who underwent DLS (DLS group); and patients with HTD diagnosed by cytological confirmation of malignancy followed by neoadjuvant chemotherapy (NACT group). RESULTS: Of 181 patients, 85, 38, and 58 underwent PDS, DLS, and NACT, respectively. Among the 38 consecutive patients who initially underwent DLS, 6 were considered suitable for PDS; the remaining 32 were eligible for NACT followed by interval debulking surgery. The median operative times of debulking surgery in the PDS, DLS, and NACT groups were 365 min (interquartile range [IQR]: 216.5–476.5 min), 266.2 min (IQR: 160.3–193.5 min), and 339.0 min (IQR: 205–425 min; P = 0.042), respectively, with respective median estimated blood loss volumes of 962.2 mL (IQR: 300–1037.5 mL), 267.1 mL (IQR: 150–450 mL), and 861.7 mL (IQR: 150–1200 mL; P = 0.023). The DLS group had significantly reduced transfusion requirements and intensive care unit admission rates (P = 0.006). The Kaplan–Meier survival analysis indicated significantly poor PFS in the NACT group. However, there was no significant difference in OS among the three groups. CONCLUSIONS: The consecutive steps of imaging, frailty assessment, and DLS might facilitate rapid assessments of peritoneal disease extent and resectability; this novel algorithm might also be used to individualize treatment. BioMed Central 2017-07-12 /pmc/articles/PMC5508631/ /pubmed/28701190 http://dx.doi.org/10.1186/s12885-017-3476-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Eoh, Kyung Jin
Yoon, Jung Won
Lee, Jung-Yun
Nam, Eun Ji
Kim, Sunghoon
Kim, Sang Wun
Kim, Young Tae
A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
title A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
title_full A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
title_fullStr A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
title_full_unstemmed A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
title_short A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
title_sort novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508631/
https://www.ncbi.nlm.nih.gov/pubmed/28701190
http://dx.doi.org/10.1186/s12885-017-3476-1
work_keys_str_mv AT eohkyungjin anovelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT yoonjungwon anovelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT leejungyun anovelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT nameunji anovelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT kimsunghoon anovelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT kimsangwun anovelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT kimyoungtae anovelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT eohkyungjin novelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT yoonjungwon novelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT leejungyun novelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT nameunji novelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT kimsunghoon novelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT kimsangwun novelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy
AT kimyoungtae novelalgorithmforthetreatmentstrategyforadvancedepithelialovariancancerconsecutiveimagingfrailtyassessmentanddiagnosticlaparoscopy